Prescription drug · ANDA
Allopurinol NDC 71335-2775
Allopurinol 100 mg/1 · Tablet · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-2775-1 | 71335277501 | 100 TABLET in 1 BOTTLE, PLASTIC (71335-2775-1)Marketed from Oct 13, 2025 | |
| 71335-2775-2 | 71335277502 | 30 TABLET in 1 BOTTLE, PLASTIC (71335-2775-2)Marketed from Oct 13, 2025 | |
| 71335-2775-3 | 71335277503 | 60 TABLET in 1 BOTTLE, PLASTIC (71335-2775-3)Marketed from Oct 13, 2025 | |
| 71335-2775-4 | 71335277504 | 120 TABLET in 1 BOTTLE, PLASTIC (71335-2775-4)Marketed from Oct 13, 2025 | |
| 71335-2775-5 | 71335277505 | 20 TABLET in 1 BOTTLE, PLASTIC (71335-2775-5)Marketed from Oct 13, 2025 | |
| 71335-2775-6 | 71335277506 | 90 TABLET in 1 BOTTLE, PLASTIC (71335-2775-6)Marketed from Oct 13, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Allopurinol
- Generic name (nonproprietary)
- allopurinol
- Active ingredients
- Allopurinol — 100 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 071450
- Marketing start
- Listing expires
- Other FDA classes
- Xanthine Oxidase Inhibitors (Mechanism)
- Identifiers
- Product ID 71335-2775_5d7a8579-0251-40bc-b4cb-81a53d2d8bf6SPL ID 5d7a8579-0251-40bc-b4cb-81a53d2d8bf6SPL set ID 156d743c-6324-44db-9230-21f762d64cfdRxCUI 197319UNII 63CZ7GJN5I
- Pharmacologic class
- Xanthine Oxidase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335277501followed by a unit qualifier and the quantityPackage 71335-2775-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Label details couldn’t be retrieved right now. Open the label on DailyMed.
Other NDCs under ANDA 071450
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Northwind Health Company, LLC | 51655-968 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | Northwind Health Company, LLC | 51655-082 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Sun Pharmaceutical Industries, Inc. | 53489-157 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | Sun Pharmaceutical Industries, Inc. | 53489-156 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Proficient Rx LP | 71205-377 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 43063-934 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 43063-935 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 43063-975 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 43063-976 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-197 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-253 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | Proficient Rx LP | 71205-208 |